[January 20, 2015] |
|
Cell Therapy Catapult and TrakCel to Collaborate on Research Project
The Cell Therapy Catapult, which is focused on the development of the UK
cell therapy industry to increase the nation's health and wealth, and
TrakCel, a provider of supply chain integration management technology
for cell therapies, today announced a research collaboration agreement
to explore the utility of TrakCel's technology in mission-critical
situations.
To test TrakCel's solution in a GMP-compliant environment, over the next
three years each company will provide resources, facilities and
personnel to form a project team. Beginning in early 2015, the Cell
Therapy Catapult will provide advisory feedback and product enhancement
input throughout the duration of the project for the benefit of
TrakCel's solution development in cell therapy planning, manufacturing,
regulatory and clinical affairs.
TrakCel technology improves cell therapy process success by proactively
instructing rofessionals within the supply chain whilst providing
real-time visibility to stakeholders. As well as reducing the
implementation risks associated with disparate, paper-based systems, the
information collected by TrakCel technology enables greater insight into
clinical trial data and provides a foundation for regulatory audits.
Keith Thompson, CEO of the Cell Therapy Catapult said: "TrakCel is
striving to improve the success of cell therapy processes by introducing
an innovative approach to cell tracking and control technology that
overcomes limitations of the existing industry methodology. Through
providing access to our experts and facilities, we're looking forward to
jointly exploring its potential."
TrakCel will install a system at the Cell Therapy Catapult for the
purpose of stress testing and analysis in a series of mission-critical
situations including inbound/outbound logistics. The project will
command a full cell process mapping exercise as well as training for
Catapult analysts and experts.
"The Cell Therapy Catapult is committed to fostering innovation and
growth in the cell therapy industry." said Kevin Smith, Director,
TrakCel. "We're excited to undertake this collaborative research project
that will provide vital input to our development team and ultimately
accelerate the advancement of our technology."
The Cell Therapy Catapult will publish its initial findings as to the
applicability of the TrakCel solution in the autumn of 2015.
TrakCel is exhibiting its cell therapy supply chain management
technology at the Phacilitate Cell & Gene Therapy Forum, January 26-28,
Washington, D.C..
[ Back To TMCnet.com's Homepage ]
|